{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:33:46Z","timestamp":1786980826069,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA154292"],"award-info":[{"award-number":["P01CA154292"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA163303"],"award-info":[{"award-number":["U54CA163303"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01 HS018366-01A1"],"award-info":[{"award-number":["R01 HS018366-01A1"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10549-019-05167-2","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T02:50:43Z","timestamp":1550803843000},"page":"519-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Validation of the breast cancer surveillance consortium model of breast cancer risk"],"prefix":"10.1007","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9857-2028","authenticated-orcid":false,"given":"Jeffrey A.","family":"Tice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C. S.","family":"Bissell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Miglioretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte C.","family":"Gard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth H.","family":"Rauscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas M.","family":"Dabbous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Kerlikowske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"5167_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy013","author":"MH Gail","year":"2018","unstructured":"Gail MH, Pfeiffer RM (2018) Breast cancer risk model requirements for counseling, prevention, and screening. J Natl Cancer Inst. \n                    https:\/\/doi.org\/10.1093\/jnci\/djy013","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"5167_CR2","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879\u20131886","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"5167_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","volume":"93","author":"B Rockhill","year":"2001","unstructured":"Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA (2001) Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93(5):358\u2013366","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"5167_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.7326\/0003-4819-148-5-200803040-00004","volume":"148","author":"JA Tice","year":"2008","unstructured":"Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K (2008) Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 148(5):337\u2013347","journal-title":"Ann Intern Med"},{"key":"5167_CR5","doi-asserted-by":"publisher","unstructured":"Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, Brandt KR, Whaley DH, Olson JE, Heusinger K, Hack CC, Jud SM, Beckmann MW, Schulz-Wendtland R, Tice JA, Norman AD, Cunningham JM, Purrington KS, Easton DF, Sellers TA, Kerlikowske K, Fasching PA, Couch FJ (2015) The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst 107 (5). \n                    https:\/\/doi.org\/10.1093\/jnci\/dju397","DOI":"10.1093\/jnci\/dju397"},{"issue":"10","key":"5167_CR6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.annepidem.2017.09.002","volume":"27","author":"GH Rauscher","year":"2017","unstructured":"Rauscher GH, Dabbous F, Dolecek TA, Friedewald SM, Tossas-Milligan K, Macarol T, Summerfelt WT (2017) Absence of an anticipated racial disparity in interval breast cancer within a large health care organization. Ann Epidemiol 27(10):654\u2013658. \n                    https:\/\/doi.org\/10.1016\/j.annepidem.2017.09.002","journal-title":"Ann Epidemiol"},{"issue":"14","key":"5167_CR7","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/jnci\/djt124","volume":"105","author":"JA Tice","year":"2013","unstructured":"Tice JA, O\u2019Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K (2013) Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst 105(14):1043\u20131049. \n                    https:\/\/doi.org\/10.1093\/jnci\/djt124","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"5167_CR8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/sim.3517","volume":"28","author":"V Viallon","year":"2009","unstructured":"Viallon V, Ragusa S, Clavel-Chapelon F, Benichou J (2009) How to evaluate the calibration of a disease risk prediction tool. Stat Med 28(6):901\u2013916. \n                    https:\/\/doi.org\/10.1002\/sim.3517","journal-title":"Stat Med"},{"issue":"2","key":"5167_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56(2):337\u2013344","journal-title":"Biometrics"},{"issue":"28","key":"5167_CR10","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1200\/JCO.2015.60.8869","volume":"33","author":"JA Tice","year":"2015","unstructured":"Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K (2015) Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer. J Clin Oncol 33(28):3137\u20133143. \n                    https:\/\/doi.org\/10.1200\/JCO.2015.60.8869","journal-title":"J Clin Oncol"},{"issue":"8","key":"5167_CR11","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/jnci\/86.8.620","volume":"86","author":"ML Bondy","year":"1994","unstructured":"Bondy ML, Lustbader ED, Halabi S, Ross E, Vogel VG (1994) Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 86(8):620\u2013625","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"5167_CR12","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","volume":"91","author":"JP Costantino","year":"1999","unstructured":"Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS (1999) Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91(18):1541\u20131548","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"5167_CR13","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1200\/JCO.2010.28.0784","volume":"28","author":"JC Boughey","year":"2010","unstructured":"Boughey JC, Hartmann LC, Anderson SS, Degnim AC, Vierkant RA, Reynolds CA, Frost MH, Pankratz VS (2010) Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. J Clin Oncol 28(22):3591\u20133596. \n                    https:\/\/doi.org\/10.1200\/JCO.2010.28.0784","journal-title":"J Clin Oncol"},{"key":"5167_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0174","author":"AR Brentnall","year":"2018","unstructured":"Brentnall AR, Cuzick J, Buist DSM, Bowles EJA (2018) Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density. JAMA Oncol. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2018.0174","journal-title":"JAMA Oncol"},{"issue":"10","key":"5167_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.7326\/M14-1465","volume":"162","author":"K Kerlikowske","year":"2015","unstructured":"Kerlikowske K, Zhu W, Tosteson AN, Sprague BL, Tice JA, Lehman CD, Miglioretti DL, Breast Cancer Surveillance C (2015) Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med 162(10):673\u2013681. \n                    https:\/\/doi.org\/10.7326\/M14-1465","journal-title":"Ann Intern Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05167-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05167-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05167-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T09:13:57Z","timestamp":1589706837000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05167-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["5167"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05167-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"5 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Jeffrey A. Tice, MD, declares that he has no conflict of interest. Michael C. S. Bissell declares that he has no conflict of interest. Diana L. Miglioretti, PhD, declares that she has no conflict of interest. Charlotte C. Gard, PhD, MBA, declares that she has no conflict of interest. Garth H. Rauscher, PhD, declares that he has no conflict of interest. Firas M. Dabbous, MS, PhD, declares that he has no conflict of interest. Karla Kerlikowske, MD, declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Each registry and the Statistical Coordinating Center received institutional review board approval and a Federal Certificate of Confidentiality and other protection for the identities of the research subjects. All procedures are Health Insurance Portability and Accountability Act (HIPAA) compliant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}